Claudio Celeghini
Overview
Explore the profile of Claudio Celeghini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
742
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sergi D, Zauli E, Celeghini C, Previati M, Zauli G
Nutr Res Rev
. 2024 Sep;
:1-11.
PMID: 39263838
Type 2 diabetes mellitus (T2DM) is a metabolic disorder that has reached epidemic proportions worldwide, posing a huge treat on people's health and quality of life. From a pathogenetic prospective,...
2.
Casciano F, Zauli E, Celeghini C, Caruso L, Gonelli A, Zauli G, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338966
Neurodegenerative diseases are an increasingly common group of diseases that occur late in life with a significant impact on personal, family, and economic life. Among these, Alzheimer's disease (AD) and...
3.
Fields M, Marcuzzi A, Gonelli A, Celeghini C, Maximova N, Rimondi E
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36835150
Neurodegenerative diseases comprise a wide spectrum of pathologies characterized by progressive loss of neuronal functions and structures. Despite having different genetic backgrounds and etiology, in recent years, many studies have...
4.
Rimondi E, Melloni E, Romani A, Tisato V, Casciano F, Rigolin G, et al.
Curr Oncol
. 2021 Jul;
28(4):2439-2451.
PMID: 34287267
In B-chronic lymphocytic leukemia (B-CLL), the interaction between leukemic cells and the microenvironment promotes tumor cell survival. The Bruton's tyrosine kinase (BTK) inhibitor ibrutinib is one of the first-in-class molecules...
5.
Piscianz E, Tesser A, Rimondi E, Melloni E, Celeghini C, Marcuzzi A
Int J Mol Sci
. 2021 May;
22(9).
PMID: 33946176
Mitoquinone (MitoQ) is a mitochondrial reactive oxygen species scavenger that is characterized by high bioavailability. Prior studies have demonstrated its neuroprotective potential. Indeed, the release of reactive oxygen species due...
6.
Ferrari D, la Sala A, Milani D, Celeghini C, Casciano F
Front Immunol
. 2021 Mar;
11:617804.
PMID: 33664731
Atherosclerosis is a hardening and narrowing of arteries causing a reduction of blood flow. It is a leading cause of death in industrialized countries as it causes heart attacks, strokes,...
7.
Bernardi S, Voltan R, Rimondi E, Melloni E, Milani D, Cervellati C, et al.
Clin Sci (Lond)
. 2019 May;
133(10):1145-1166.
PMID: 31097613
Ligands and receptors of the tumor necrosis factor (TNF) superfamily regulate immune responses and homeostatic functions with potential diagnostic and therapeutic implications. Kidney disease represents a global public health problem,...
8.
Tisato V, Gallo S, Melloni E, Celeghini C, Passaro A, Zauli G, et al.
Mediators Inflamm
. 2018 Aug;
2018:9629537.
PMID: 30147446
Objective: "Oxinflammation" is a recently coined term that defines the deleterious crosstalk between inflammatory and redox systemic processes, which underlie several diseases. Oxinflammation could be latently responsible for the predisposition...
9.
Marcuzzi A, Loganes C, Valencic E, Piscianz E, Monasta L, Bilel S, et al.
Int J Mol Sci
. 2018 May;
19(5).
PMID: 29783748
Cholesterol metabolism is crucial for cells and, in particular, its biosynthesis in the central nervous system occurs in situ, and its deregulation involves morphological changes that cause functional variations and...
10.
Agostinis C, Rami D, Zacchi P, Bossi F, Stampalija T, Mangogna A, et al.
Am J Reprod Immunol
. 2018 Feb;
79(4):e12823.
PMID: 29427369
Problem: Procalcitonin (PCT) is the prohormone of calcitonin which is usually released from neuroendocrine cells of the thyroid gland (parafollicular) and the lungs (K cells). PCT is synthesized by almost...